- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04135339
Efficacy of Exercise on Post Needling Soreness
Introduction. The myofascial trigger point (MTrP) is a clinical entity related to different clinical pictures of pain. Dry needling (DN) would be the most appropriate therapeutic option for its treatment, although it has mild-moderate adverse effects, such as post-needling soreness (PNS). The exercise could be a strategy for its management, but no recommendations on the most effective mode have been found.
Objectives
- To determine the effectiveness of the exercise, differentiated according to the dominant mode (concentric, eccentric, isometric), in order to reduce the PNS of latent MTrPs.
- To analyse the variables that, a priori, can influence the evolution of pain.
Methods. Study design .A randomized clinical trial. Scenario Private or home-based consultation in Global Physiotherapy, Madrid, Spain.
Participants. Voluntaries, with no symptoms in the triceps surae muscle,>18 years old, who present at least one latent MTrP in medial gastrocnemius. Subjects with: other pathologies of lower limbs, active MTrP in the medial gastrocnemius muscle, contraindications to DN, prior application of DN and/or other therapies in MTrPs during the three months previous to the study (in gastrocnemius muscles) will be excluded.
Intervention After DN of the medial gastrocnemius muscle, participants will be randomly allocated to four groups (three experimental groups and one control). In the experimental groups, subjects will be instructed to perform exercise protocols, differentiated according to the dominant contraction (concentric, eccentric, isometric) in muscle the gastrocnemius previously treated.
Outcome measures. Pain intensity, by analog visual scale (VAS). Pressure pain threshold (PPT), by analog algometer. Demographics and anthropometrics.
Protocol. Before and immediately after DN, the PPT will be evaluated in the latent MTrP. Pain intensity will also be assessed using VAS at two times: the first referred to pain during DN and the other referred to PNS two minutes after DN. The subjects will then be randomly divided into: a control group without any intervention after DN, and three experimental groups with different exercise protocols (differentiated by the dominant contraction: 3 sets x 15 reps, 3s each contraction, 30s of rest between sets) . The pain intensity will be recorded again by VAS, after the exercise session and at 6h, 12h, 24h, 48h, 72h after DN. PPT will also be assessed 2min after DN, after the exercise session and at 24h, and 48h after DN.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction. The myofascial trigger point (MTrP) is a clinical entity related to different clinical pictures of pain. Dry needling (DN) would be the most appropriate therapeutic option for its treatment, although it has mild-moderate adverse effects, such as post-needling soreness (PNS). The exercise could be a strategy for its management, but no recommendations on the most effective mode have been found.
Objectives
- To determine the effectiveness of the exercise, differentiated according to the dominant mode (concentric, eccentric, isometric), in order to reduce the PNS of latent MTrPs.
- To analyse the variables that, a priori, can influence the evolution of pain.
Methods Study design A randomized clinical trial. Scenario Private or home-based consultation in Global Physiotherapy, Madrid, Spain.
Participants. Voluntaries, with no symptoms in the triceps surae muscle,>18 years old, who present at least one latent MTrP in medial gastrocnemius. Subjects with: other pathologies of lower limbs, active MTrP in the medial gastrocnemius muscle, contraindications to DN, prior application of DN and/or other therapies in MTrPs during the three months previous to the study (in gastrocnemius muscles) will be excluded.
Intervention After DN of the medial gastrocnemius muscle, participants will be randomly allocated to four groups (three experimental groups and one control). In the experimental groups, subjects will be instructed to perform exercise protocols, differentiated according to the dominant contraction (concentric, eccentric, isometric) in muscle the gastrocnemius previously treated.
Outcome measures. Pain intensity, by analog visual scale (VAS). Pressure pain threshold (PPT), by analog algometer. Demographics and anthropometrics.
Protocol. Before and immediately after DN, the PPT will be evaluated in the latent MTrP. Pain intensity will also be assessed using VAS at two times: the first referred to pain during DN and the other referred to PNS two minutes after DN. The subjects will then be randomly divided into: a control group without any intervention after DN, and three experimental groups with different exercise protocols (differentiated by the dominant contraction: 3 sets x 15 reps, 3s each contraction, 30s of rest between sets) . The pain intensity will be recorded again by VAS, after the exercise session and at 6h, 12h, 24h, 48h, 72h after DN. PPT will also be assessed 2min after DN, after the exercise session and at 24h, and 48h after DN.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28003
- Nicola Sante Diciolla
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presence of at least one latent myofascial trigger point (MTrP) in the medial gastrocnemius muscle.
Exclusion Criteria:
- Other lower limb pathologies which no permit the application of the interventions (e.g. lower limb fractures; sprain in acute phase; etc).
- Active MTrPs in the medial gastrocnemius muscle (related to tendinopathies, plantar fascitis).
- Fibromyalgia.
- Osteosynthesis materials.
- Pregnancy.
- Fear of needles.
- Previous application of dry needling (in gastrocnemius muscles).
- Other treatments of MTrPs during the three months previous to the study (in gastrocnemius muscles).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group A. Eccentric exercise.
15 subjects with a latent myofascial trigger point in the medial gastrocnemius muscle.
|
The exercise session will consist of 3 sets of 15 reps, 3´´ per rep, with 30'' rest between sets, of the previous treated gastrocnemius muscle (by DN).
Each rep will be a pure eccentric contraction.
|
Experimental: Group B. Concentric exercise.
15 subjects with a latent myofascial trigger point in the medial gastrocnemius muscle.
|
The exercise session will consist of 3 sets of 15 reps, 3´´ per rep, with 30'' rest between sets, of the previous treated gastrocnemius muscle (by DN).
Each rep will be a pure concentric contraction.
|
Experimental: Group C. Isometric exercise.
15 subjects with a latent myofascial trigger point in the medial gastrocnemius muscle.
|
The exercise session will consist of 3 sets of 15 reps, 3´´ per rep, with 30'' rest between sets, of the previous treated gastrocnemius muscle (by DN).
Each rep will be a pure isometric contraction.
|
No Intervention: Group D. Control.
15 subjects with a latent myofascial trigger point in the medial gastrocnemius muscle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of post needling soreness.
Time Frame: 2 minutes after dry needling, just after exercise session (not for control group), 6 hours after exercise session, 12 hours after exercise session, 24 hours after dry exercise session, 48 hours after exercise session, 72 hours after exercise session.
|
Visual analog scale (VAS) of 100 mm: 0 mm indicates absence of post needling soreness and 100 mm indicates maximum post needling soreness intensity
|
2 minutes after dry needling, just after exercise session (not for control group), 6 hours after exercise session, 12 hours after exercise session, 24 hours after dry exercise session, 48 hours after exercise session, 72 hours after exercise session.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of pressure pain threshold after dry needling.
Time Frame: 2 minutes after dry needling, just after exercise session (not for control group), 24 hours after exercise session, 48 hours after exercise session.
|
Analog algometer (kilograms/squared centimeters -kg/cm2-).
|
2 minutes after dry needling, just after exercise session (not for control group), 24 hours after exercise session, 48 hours after exercise session.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity during dry needling
Time Frame: Before exercise session (i.e. during dry needling).
|
Visual analog scale (VAS) of 100 mm: 0 mm indicates absence of pain and 100 mm indicates maximum pain intensity.
|
Before exercise session (i.e. during dry needling).
|
Pressure pain threshold before dry needling
Time Frame: Before intervention (i.e. dry needling and exercise session).
|
Analog algometer (kilograms/squared centimeters -kg/cm2-).
|
Before intervention (i.e. dry needling and exercise session).
|
Demographic data.
Time Frame: First assessment before intervention (i.e. dry needling and exercise session).
|
Age (years).
|
First assessment before intervention (i.e. dry needling and exercise session).
|
Demographic data.
Time Frame: First assessment before intervention (i.e. dry needling and exercise session).
|
Gender (male/female).
|
First assessment before intervention (i.e. dry needling and exercise session).
|
Anthropometric data.
Time Frame: First assessment before intervention (i.e. dry needling and exercise session).
|
Height (meters -m-).
|
First assessment before intervention (i.e. dry needling and exercise session).
|
Anthropometric data.
Time Frame: First assessment before intervention (i.e. dry needling and exercise session).
|
Weight (kilograms-kg-).
|
First assessment before intervention (i.e. dry needling and exercise session).
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: María Torres Lacomba, PT, PhD, University of Alcalá, Madrid, Spain.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEI/HU/2019/27
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
- Research interest in effects of exercise on post needling soreness.
- Ethical Committee approval.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myofascial Pain
-
Bozyaka Training and Research HospitalEnrolling by invitationMyofascial Pain | Trigger Point Pain, Myofascial | Myofascial Trigger Point PainTurkey
-
Washington University School of MedicineRecruitingMyofascial Pain | Pelvic Pain | Pelvic Floor Myofascial PainUnited States
-
Universidad Complutense de MadridUnknownNeck Pain | Myofascial Pain | Myofascial Pain Syndrome | Myofascial Trigger Point PainSpain
-
Beth Israel Deaconess Medical CenterMassachusetts General HospitalRecruitingMyofascial Pain | Trigger Point Pain, MyofascialUnited States
-
University of ArizonaEnrolling by invitationMyofascial Pain | Myofascial Trigger Point PainUnited States
-
Universidad Complutense de MadridCompletedMyofascial Pain | Trigger Point Pain, MyofascialSpain
-
Universidad Complutense de MadridRecruitingTrigger Point Pain, Myofascial | Myofascial Pain Syndrome of Neck | Myofacial PainSpain
-
Quiropraxia y EquilibrioUniversidad Nacional Andres BelloCompletedMyofascial Trigger Point Pain (MTrP)Chile
-
Medical University InnsbruckCompletedMyofascial Pain | Myofascial Trigger Point Pain | Pain, Back | Pain, Neck | Mitochondrial Pathology
-
University Hospitals Cleveland Medical CenterAllerganCompletedMyofascial Pain Syndromes | Trigger Point Pain, Myofascial | Myofascial Trigger Point PainUnited States
Clinical Trials on Eccentric exercise
-
University of MalagaUnknownRotator Cuff Tendinopathy
-
Oslo University HospitalUniversity of OsloCompleted
-
Queen Margaret UniversityUnknownTendinopathy | Achilles TendonUnited Kingdom
-
Universidad Europea de MadridCompletedAchilles Tendinopathy | Diastasis RectiSpain
-
Utah State UniversityNot yet recruitingBlood Flow Restriction
-
Universidad Europea de MadridCompletedTendinopathy | Achilles TendonSpain
-
New York Institute of TechnologyRecruitingHypermobility SyndromeUnited States
-
Centre Hospitalier Universitaire de BesanconUnknownVentilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD (CONvEX)Chronic Obstructive Pulmonary Disease SevereFrance
-
University Hospital, Clermont-FerrandUnknown
-
Uppsala UniversityThe Swedish Research Council; Uppsala County Council, Sweden; Amersham FoundationCompleted